✦ LIBER ✦

865 Phase IIB, Randomized, Placebo-Controlled Evaluation of the Efficacy and Safety of Induction Therapy With Eldelumab (Anti-IP-10 Antibody; BMS-936557) in Patients With Active Ulcerative Colitis

✍ Scribed by Sandborn, William J.; Colombel, Jean-Frederic; Ghosh, Subrata; Sands, Bruce E.; Xu, Li-An; Luo, Allison

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

943d A Phase 2/3 Randomized, Placebo-con

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

159 Differentiation Between Etrolizumab

✍ Vermeire, Severine; O'Byrne, Sharon; Williams, Marna; Mansfield, John C.; Feagan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 434 KB

A phase II, randomized, double-blind, pl

✍ Michael Yellin; Igor Paliienko; Andra Balanescu; Semen Ter-Vartanian; Vira Tselu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

46 A Phase 2a Randomized Placebo-Control

✍ Severine Vermeire; Paul J. Rutgeerts; Geert R. D'Haens; Martine De Vos; Brian Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB